ADMA Biologics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for ADMA Biologics, Inc. (ADMA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents103.1551.3586.5251.0955.9226.7522.75
Cash & Short-Term Investments103.1551.3586.5251.0955.9226.7522.75
Accounts Receivable50.0027.4215.5128.5813.243.471.39
Inventory170.24172.91163.28124.7281.5453.0618.62
Other Current Assets8.035.335.104.343.050.000.00
Total Current Assets331.41257.01270.40208.73153.7485.8244.53
Non-Current Assets
Property, Plant & Equipment (Net)63.3463.4768.7558.2045.8532.9930.12
Goodwill3.533.533.533.533.530.000.00
Intangible Assets0.460.501.011.732.440.000.00
Other Non-Current Assets5.664.674.774.072.110.005.15
Total Non-Current Assets157.2772.1778.0667.5253.9041.2744.35
Total Assets488.68329.18348.46276.25207.67127.0988.88
Current Liabilities
Accounts Payable20.2215.6613.2312.4311.0713.669.45
Short-Term Debt2.440.000.000.000.000.000.00
Accrued Liabilities28.6330.5523.1916.208.160.000.00
Deferred Revenue0.140.180.140.140.140.000.00
Other Current Liabilities1.852.371.801.010.210.000.00
Total Current Liabilities55.5449.8139.2730.3819.9514.039.63
Non-Current Liabilities
Long-Term Debt72.34130.59142.8394.8792.9783.2044.19
Other Non-Current Liabilities1.672.111.850.400.050.1112.88
Total Non-Current Liabilities84.12144.17157.22104.7099.4886.8759.48
Total Liabilities139.66193.98196.49135.08119.42100.9069.11
Stockholders' Equity
Common Stock0.020.020.020.020.010.000.00
Retained Earnings-308.58-506.26-478.02-412.11-340.47-264.72-216.44
Additional Paid-in Capital657.58641.44629.97553.27428.70290.90236.20
Shares Outstanding236.62226.06221.82195.810.000.000.00
Total Stockholders' Equity349.02135.21151.97141.1788.2526.1919.77
Total Liabilities & Equity488.68329.18348.46276.25207.64127.0988.88